| William C Kramer, MD | |
|
4740 Pearl Pkwy Ste 200, Boulder, CO 80301-3080 | |
| (303) 449-2730 | |
| (303) 449-5821 |
| Full Name | William C Kramer |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 16 Years |
| Location | 4740 Pearl Pkwy Ste 200, Boulder, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093978223 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 94-06920 (Kansas) | Secondary |
| 207X00000X | Orthopaedic Surgery | DR0053611 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wray Community District Hospital | Wray, CO | Hospital |
| Boulder Community Health | Boulder, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bouldercentre For Orthopedics Pc | 3971409020 | 50 |
| Wray Community District Hospital | 3274425038 | 26 |
News Archive
A recent Washington Post editorial "wrongly criticized" Sen. Tom Coburn (R-Okla.) and "his colleagues for conducting due diligence" regarding legislation to reauthorize the President's Emergency Plan for AIDS Relief, Sen. Judd Gregg (N.H.), ranking Republican on the Senate Budget Committee's Appropriations Subcommittee on State and Foreign Operations, writes in a Post letter to the editor (Gregg, Washington Post, 6/5).
There have been significant efforts worldwide to combat COVID-19, the disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). One prominent strategy has been to develop vaccines against the virus. Numerous vaccine candidates are under development, and a handful have now been approved for use by several countries.
NeuroVive Pharmaceutical and Hospices Civils de Lyon (HCL) today announced the enrollment and treatment of the first patient in the European multicenter trial of myocardial infarction (the CIRCUS study). NeuroVive's advanced CicloMulsion(TM) cremophor-free IV cyclosporine formulation is used in this study of 1,000 patients undergoing percutaneous coronary intervention (PCI) for acute myocardial infarction to examine cyclosporine's ability to protect cardiac tissue.
On the cusp of the recent Centers for Disease Control and Prevention report about the growing death toll from prescription drug deaths, the physician leadership of the American Academy of Pain Medicine announced its plans to roll-out a new education initiative: Safe Opioid Prescribing: Reversing the Trends.
Young women with ADHD who have been exposed to abuse, neglect or other traumas in childhood and adolescence are at greater risk for self-injury, eating disorders and suicide than those with ADHD who were not mistreated in early youth, according to new research from UC Berkeley.
› Verified 9 days ago
| Entity Name | Bouldercentre For Orthopedics Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336197631 PECOS PAC ID: 3971409020 Enrollment ID: O20031209000994 |
News Archive
A recent Washington Post editorial "wrongly criticized" Sen. Tom Coburn (R-Okla.) and "his colleagues for conducting due diligence" regarding legislation to reauthorize the President's Emergency Plan for AIDS Relief, Sen. Judd Gregg (N.H.), ranking Republican on the Senate Budget Committee's Appropriations Subcommittee on State and Foreign Operations, writes in a Post letter to the editor (Gregg, Washington Post, 6/5).
There have been significant efforts worldwide to combat COVID-19, the disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). One prominent strategy has been to develop vaccines against the virus. Numerous vaccine candidates are under development, and a handful have now been approved for use by several countries.
NeuroVive Pharmaceutical and Hospices Civils de Lyon (HCL) today announced the enrollment and treatment of the first patient in the European multicenter trial of myocardial infarction (the CIRCUS study). NeuroVive's advanced CicloMulsion(TM) cremophor-free IV cyclosporine formulation is used in this study of 1,000 patients undergoing percutaneous coronary intervention (PCI) for acute myocardial infarction to examine cyclosporine's ability to protect cardiac tissue.
On the cusp of the recent Centers for Disease Control and Prevention report about the growing death toll from prescription drug deaths, the physician leadership of the American Academy of Pain Medicine announced its plans to roll-out a new education initiative: Safe Opioid Prescribing: Reversing the Trends.
Young women with ADHD who have been exposed to abuse, neglect or other traumas in childhood and adolescence are at greater risk for self-injury, eating disorders and suicide than those with ADHD who were not mistreated in early youth, according to new research from UC Berkeley.
› Verified 9 days ago
| Entity Name | Wray Community District Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477587202 PECOS PAC ID: 3274425038 Enrollment ID: O20040326000383 |
News Archive
A recent Washington Post editorial "wrongly criticized" Sen. Tom Coburn (R-Okla.) and "his colleagues for conducting due diligence" regarding legislation to reauthorize the President's Emergency Plan for AIDS Relief, Sen. Judd Gregg (N.H.), ranking Republican on the Senate Budget Committee's Appropriations Subcommittee on State and Foreign Operations, writes in a Post letter to the editor (Gregg, Washington Post, 6/5).
There have been significant efforts worldwide to combat COVID-19, the disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). One prominent strategy has been to develop vaccines against the virus. Numerous vaccine candidates are under development, and a handful have now been approved for use by several countries.
NeuroVive Pharmaceutical and Hospices Civils de Lyon (HCL) today announced the enrollment and treatment of the first patient in the European multicenter trial of myocardial infarction (the CIRCUS study). NeuroVive's advanced CicloMulsion(TM) cremophor-free IV cyclosporine formulation is used in this study of 1,000 patients undergoing percutaneous coronary intervention (PCI) for acute myocardial infarction to examine cyclosporine's ability to protect cardiac tissue.
On the cusp of the recent Centers for Disease Control and Prevention report about the growing death toll from prescription drug deaths, the physician leadership of the American Academy of Pain Medicine announced its plans to roll-out a new education initiative: Safe Opioid Prescribing: Reversing the Trends.
Young women with ADHD who have been exposed to abuse, neglect or other traumas in childhood and adolescence are at greater risk for self-injury, eating disorders and suicide than those with ADHD who were not mistreated in early youth, according to new research from UC Berkeley.
› Verified 9 days ago
| Entity Name | Wray Community District Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1083640239 PECOS PAC ID: 3274425038 Enrollment ID: O20161220001701 |
News Archive
A recent Washington Post editorial "wrongly criticized" Sen. Tom Coburn (R-Okla.) and "his colleagues for conducting due diligence" regarding legislation to reauthorize the President's Emergency Plan for AIDS Relief, Sen. Judd Gregg (N.H.), ranking Republican on the Senate Budget Committee's Appropriations Subcommittee on State and Foreign Operations, writes in a Post letter to the editor (Gregg, Washington Post, 6/5).
There have been significant efforts worldwide to combat COVID-19, the disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). One prominent strategy has been to develop vaccines against the virus. Numerous vaccine candidates are under development, and a handful have now been approved for use by several countries.
NeuroVive Pharmaceutical and Hospices Civils de Lyon (HCL) today announced the enrollment and treatment of the first patient in the European multicenter trial of myocardial infarction (the CIRCUS study). NeuroVive's advanced CicloMulsion(TM) cremophor-free IV cyclosporine formulation is used in this study of 1,000 patients undergoing percutaneous coronary intervention (PCI) for acute myocardial infarction to examine cyclosporine's ability to protect cardiac tissue.
On the cusp of the recent Centers for Disease Control and Prevention report about the growing death toll from prescription drug deaths, the physician leadership of the American Academy of Pain Medicine announced its plans to roll-out a new education initiative: Safe Opioid Prescribing: Reversing the Trends.
Young women with ADHD who have been exposed to abuse, neglect or other traumas in childhood and adolescence are at greater risk for self-injury, eating disorders and suicide than those with ADHD who were not mistreated in early youth, according to new research from UC Berkeley.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William C Kramer, MD 4740 Pearl Parkway, Suite 200, Boulder, CO 80301-3078 Ph: (303) 449-2730 | William C Kramer, MD 4740 Pearl Pkwy Ste 200, Boulder, CO 80301-3080 Ph: (303) 449-2730 |
News Archive
A recent Washington Post editorial "wrongly criticized" Sen. Tom Coburn (R-Okla.) and "his colleagues for conducting due diligence" regarding legislation to reauthorize the President's Emergency Plan for AIDS Relief, Sen. Judd Gregg (N.H.), ranking Republican on the Senate Budget Committee's Appropriations Subcommittee on State and Foreign Operations, writes in a Post letter to the editor (Gregg, Washington Post, 6/5).
There have been significant efforts worldwide to combat COVID-19, the disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). One prominent strategy has been to develop vaccines against the virus. Numerous vaccine candidates are under development, and a handful have now been approved for use by several countries.
NeuroVive Pharmaceutical and Hospices Civils de Lyon (HCL) today announced the enrollment and treatment of the first patient in the European multicenter trial of myocardial infarction (the CIRCUS study). NeuroVive's advanced CicloMulsion(TM) cremophor-free IV cyclosporine formulation is used in this study of 1,000 patients undergoing percutaneous coronary intervention (PCI) for acute myocardial infarction to examine cyclosporine's ability to protect cardiac tissue.
On the cusp of the recent Centers for Disease Control and Prevention report about the growing death toll from prescription drug deaths, the physician leadership of the American Academy of Pain Medicine announced its plans to roll-out a new education initiative: Safe Opioid Prescribing: Reversing the Trends.
Young women with ADHD who have been exposed to abuse, neglect or other traumas in childhood and adolescence are at greater risk for self-injury, eating disorders and suicide than those with ADHD who were not mistreated in early youth, according to new research from UC Berkeley.
› Verified 9 days ago
Jennah Mann, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 2150 Stadium Dr 2nd Floor, Boulder, CO 80309 Phone: 720-848-0000 | |
Dr. Stephen D Paul, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4740 Pearl Pkwy Ste 200, Boulder, CO 80301 Phone: 303-449-2730 Fax: 303-449-2730 | |
Dr. James B Rector, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4740 Pearl Pkwy Ste 200, Boulder, CO 80301 Phone: 303-449-2790 Fax: 303-449-5821 | |
Brian Patrick Davis, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 4740 Pearl Pkwy Ste 200, Boulder, CO 80301 Phone: 303-449-2730 | |
Robert A Harper, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4740 Pearl Pkwy Ste 200, Boulder, CO 80301 Phone: 303-449-2730 | |
Dirk Dolbeare, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4740 Pearl Pkwy Ste 200, Boulder, CO 80301 Phone: 303-449-2730 Fax: 303-449-5821 |